Cargando…
Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212484/ http://dx.doi.org/10.1016/S0016-5085(22)61416-1 |
| _version_ | 1784730605806682112 |
|---|---|
| author | Doherty, Jayne Stack, Roisin O'Morain, Neil Girod, Parker Tosetto, Miriam Inzitari, Rosanna Sheridan, Juliette Cullen, Garret Buckley, Maire Mulcahy, Hugh E. Ryan, Elizabeth J. Daghfal, David J Doran, Peter O'Morain, Colm A. Doherty, Glen |
| author_facet | Doherty, Jayne Stack, Roisin O'Morain, Neil Girod, Parker Tosetto, Miriam Inzitari, Rosanna Sheridan, Juliette Cullen, Garret Buckley, Maire Mulcahy, Hugh E. Ryan, Elizabeth J. Daghfal, David J Doran, Peter O'Morain, Colm A. Doherty, Glen |
| author_sort | Doherty, Jayne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92124842022-06-22 Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) Doherty, Jayne Stack, Roisin O'Morain, Neil Girod, Parker Tosetto, Miriam Inzitari, Rosanna Sheridan, Juliette Cullen, Garret Buckley, Maire Mulcahy, Hugh E. Ryan, Elizabeth J. Daghfal, David J Doran, Peter O'Morain, Colm A. Doherty, Glen Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212484/ http://dx.doi.org/10.1016/S0016-5085(22)61416-1 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Doherty, Jayne Stack, Roisin O'Morain, Neil Girod, Parker Tosetto, Miriam Inzitari, Rosanna Sheridan, Juliette Cullen, Garret Buckley, Maire Mulcahy, Hugh E. Ryan, Elizabeth J. Daghfal, David J Doran, Peter O'Morain, Colm A. Doherty, Glen Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title | Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title_full | Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title_fullStr | Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title_full_unstemmed | Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title_short | Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION) |
| title_sort | su1494: reduced serological response to covid-19 vaccines in patients with ibd is further diminished by tnf inhibitor therapy; early results of the variation study (variability in response in ibd against sars-cov2-immunisation) |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212484/ http://dx.doi.org/10.1016/S0016-5085(22)61416-1 |
| work_keys_str_mv | AT dohertyjayne su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT stackroisin su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT omorainneil su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT girodparker su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT tosettomiriam su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT inzitarirosanna su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT sheridanjuliette su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT cullengarret su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT buckleymaire su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT mulcahyhughe su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT ryanelizabethj su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT daghfaldavidj su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT doranpeter su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT omoraincolma su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation AT dohertyglen su1494reducedserologicalresponsetocovid19vaccinesinpatientswithibdisfurtherdiminishedbytnfinhibitortherapyearlyresultsofthevariationstudyvariabilityinresponseinibdagainstsarscov2immunisation |